769-19-7 Usage
Uses
Used in Pharmaceutical Industry:
4-Bromo-benzothiazol-5-ylamine is used as a building block for the development of new pharmaceuticals due to its unique chemical structure that can be modified to create a variety of biologically active molecules. Its presence in drug synthesis can lead to the discovery of novel therapeutic agents with improved efficacy and selectivity.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Bromo-benzothiazol-5-ylamine is utilized as a precursor in the synthesis of agrochemicals, potentially enhancing crop protection and yield through the development of new pesticides and other agricultural chemicals.
Used in Chemical Research and Development:
4-Bromo-benzothiazol-5-ylamine serves as a versatile reagent in chemical research, facilitating the exploration of new chemical reactions and the synthesis of innovative compounds with potential applications in various fields, including but not limited to medicine and agriculture. Its adaptability in chemical reactions makes it a valuable tool for advancing scientific knowledge and creating new chemical entities.
Check Digit Verification of cas no
The CAS Registry Mumber 769-19-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,6 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 769-19:
(5*7)+(4*6)+(3*9)+(2*1)+(1*9)=97
97 % 10 = 7
So 769-19-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H5BrN2S/c8-6-4(9)1-2-5-7(6)10-3-11-5/h1-3H,9H2
769-19-7Relevant academic research and scientific papers
ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
-
Paragraph 00507, (2013/10/08)
Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
CHEMICAL COMPOUNDS
-
Page/Page column 23-24, (2009/05/28)
The use of a compound of formula I wherein Y is a single bond, C═O, C═S or S(O)m, where m is 0, 1 or 2; the ring is a 6-membered aromatic or is a 5 or 6 membered heteroaromatic ring; Z and Z′ are joined by a single or a double bond and are ═C—
Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
-
, (2008/06/13)
This invention involves compounds having the following structure: as described in the Claims; and enantiomers, optical isomers, stereoisomers, diastereomers, tautomers, addition salts, biohydrolyzable amides and esters thereof, as well as pharmaceutical compositions comprising such novel compounds. The invention also relates to the use of such compounds for preventing or treating disorders modulated by alpha-2 adrenoceptors.
